SEC filings and other documents

R&D investments target high-margin growth in dermacosmetics and semiconductors, leveraging unique technologies.

AI-driven marketing tools and agile global teams are accelerating growth and efficiency worldwide.

Q1 delivered strong profit growth and margin gains, with full-year outlook unchanged.

Strong FY25 results and FY26 growth outlook, with focus on innovation and global expansion.

Strong profit growth and margin expansion driven by recovery in cosmetics and cost controls.

Targets JPY 400B sales and 15% margin by 2027 via global brand focus and operational efficiency.

Upward forecast revision reflects robust earnings, market share gains, and strategic reforms.

Sales and profits rose sharply, led by cosmetics and UV Care, with guidance unchanged.

Profit and margin growth exceeded targets, with 2025 set for further gains and global expansion.

Profitability surged on reforms and premiumization, offsetting China cosmetics weakness.

Profit up 68% year-over-year; full-year outlook raised, but China cosmetics weak.